Libertad Rosell

发表

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study

A. Guerrero-Zotano, S. González, M. Pollán, 2022, Cancers.

Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial

J. Albanell, M. Ramos, M. Casas, 2023, Therapeutic advances in medical oncology.

Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study.

A. Guerrero-Zotano, M. Pollán, J. García-Saenz, 2024, The journal of nutrition, health & aging.